Platelet-rich plasma (PRP) · Lesson 14 of 25 · 3 min

Does PRP help fractures heal? The evidence on bone healing and non-union

PRP for bone healing has a clear rationale but a contradictory evidence base. Non-union data are the most supportive, and routine use in ordinary fractures is not supported.

Gloved hands placing a sample tube into a centrifuge

Key takeaways.

  • Bone usually heals well on its own, which sets a high bar for showing any added benefit.
  • The most supportive data are in delayed union and non-union, where natural healing has stalled.
  • A 2024 review concluded that routine PRP use for primary fracture healing cannot be supported.
  • Studies of PRP added to bone graft in spinal fusion have been disappointing.
  • Wide variation in PRP preparations makes studies hard to compare.
  • Reported safety is good, with virtually no serious adverse events in the reviewed studies.

The rationale

Bone heals in three overlapping phases: inflammation, repair and remodeling. Growth factors found in platelets, including PDGF, TGF-beta, VEGF and IGF-1, help regulate stem cell recruitment, bone cell formation and new blood vessel growth.

Platelet-rich plasma (PRP) concentrates these factors. The question researchers ask is whether adding them improves on a process that normally succeeds without help.

What the evidence shows

The strongest signal is in delayed union and non-union, where a fracture heals slowly or stops healing. A 2024 umbrella meta-analysis reported a higher healing rate with PRP (relative risk 1.30, 95% CI 1.06 to 1.60) and healing time shorter by 1.25 months compared with controls.

For ordinary acute fractures, the picture is mixed. A 2024 review found that 19 of 24 clinical studies reported favorable outcomes. The same review still concluded that routine use of PRP for primary fracture healing and non-union management cannot be supported, because the studies differ so much.

In spinal fusion, multiple studies found no significant difference, or even lower fusion rates, when PRP was added to autograft.

Why results conflict

Studies use different platelet concentrations, white cell content, activation methods, delivery routes and timing. They also enroll different fracture types. This makes it nearly impossible to identify a best protocol or the patients most likely to benefit.

Timing is another cited limit. Activated PRP is described as releasing growth factors over about a week, while bone takes months to regain strength. Research is exploring carriers that release factors more slowly, and combinations with bone morphogenetic proteins.

Where this leaves clinicians

The course material concludes that PRP should be considered investigational for most bone healing uses, with established delayed union or non-union as the possible exception.

PRP applications are considered off-label. Well-designed trials with standardized preparations are still needed.

Educational content for healthcare professionals. Not a treatment recommendation. PRP applications are considered off-label.

Platelet-rich plasma (PRP): 0 of 25 lessons finished

All lessons

This guide covers the what and the why.

The how is taught live. The webinar and live training go deeper on:

  • Bone healing biology and where PRP may fit in the timeline
  • Reading the non-union and delayed union literature
  • Use of PRP with bone grafts and other biologics
  • Preparation variables that affect study results
  • Counseling patients on investigational status

Common questions.

Should PRP be used routinely for fresh fractures?
Current evidence does not support that. A 2024 review concluded routine use to enhance primary fracture healing cannot be supported, citing extensive variation across studies.
Is there evidence for PRP in non-union fractures?
This is where the data are most supportive. A 2024 umbrella meta-analysis reported a higher healing rate and shorter healing time with PRP than with controls, though protocols are not standardized.
Does PRP improve spinal fusion rates?
Studies to date have been disappointing. Several found no significant difference, or lower fusion rates, when PRP was added to autograft.

Sources

  • Liu X, et al. Platelet-rich plasma in the treatment of delayed union and nonunion fractures: An umbrella meta-analysis. Injury. 2024;55(12):111972.
  • Liao H, et al. Advances with Platelet-Rich Plasma for Bone Healing. Biologics. 2024;18:47-66.
  • Pérez-España LA, et al. Efficacy of using autologous cells with graft substitutes for spinal fusion surgery: A systematic review and meta-analysis of clinical outcomes and imaging features. JOR Spine. 2024;7(2):e1348.

Ready for the hands-on detail?

Live on Zoom, Tuesdays at 12:00 PM ET. See how the model works before you commit to anything.